Sustained-release praziquantel tablet: pharmacokinetics and the treatment of clonorchiasis in beagle dogs (original) (raw)

Abstract

Praziquantel is rapidly absorbed and secreted; and thus fractional doses are recommended for the treatment of cestode and trematode infections. In the present study, we developed a new praziquantel tablet formula allowing sustained-release (SRP). In vitro dissolution of SRP tablets showed that praziquantel at 300 mg/tablet combined with hydroxypropyl methylcellulose dissolved completely at a constant rate over 10 h, whereas the conventional praziquantel tablet (PZQ) was only 40% dissolved. Pharmacokinetic studies in dogs confirmed that SRP was absorbed more slowly than PZQ. The mean value of the area under the concentration/time curve from 0 h to the final observation time, the maximum concentration in serum, and the time of maximum concentration in serum for SRP were 3,471,500 ng/min for 0.25 ml, 10,300 ng for 0.25 ml, and 192 min, while the values for PZQ were 688,600 ng/min for 0.25 ml, 2,500 ng for 0.25 ml, and 135 min. The cure rate in dogs with a heavy infection (500 metacercariae) treated with a single dose of SRP (150 mg/tablet) at 50 mg/kg was 80%, while in dogs treated with a single dose of SRP (300 mg/tablet) at 30 mg/kg it was 60%, and the cure rate with PZQ was 20%. In each case, the egg reduction rate was similar (over 90%). No abnormal liver functions or hepatic or renal pathologies were observed in dogs administered with SRP at 30 mg/kg. The SRP tablet showed sustained release and slow absorption; and it had an improved anthelmintic efficacy against Clonorchis sinensis in experimental dogs, compared with conventional praziquantel.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Download references

Acknowledgements

The present study was supported by a grant from the Ministry of Health and Welfare, Korea (HMP-98-D-7-0024). We appreciate the assistance of the Shinpoong Pharmaceutical Co. in preparing SRP tablets and monitoring the concentration of praziquantel in dog sera.

Author information

Authors and Affiliations

  1. Department of Parasitology and Tropical Medicine, and Institute of Endemic Diseases, Seoul National University College of Medicine, Seoul 110-799, Korea
    Sung-Tae Hong, Sang Hyup Lee, Mejeong Lee, Shunyu Li, Byung-Suk Chung & Min-Ho Choi
  2. College of Pharmacy, Ewha Womans University, Seoul 120-750, Korea
    Seung-Jin Lee
  3. Department of Parasitology, Inje University College of Medicine, Busan 614-735, Korea
    Weon-Gyu Kho
  4. Department of Parasitology, Dankuk University College of Medicine, Cheonan 330-714, Korea
    Min Seo

Authors

  1. Sung-Tae Hong
  2. Sang Hyup Lee
  3. Seung-Jin Lee
  4. Weon-Gyu Kho
  5. Mejeong Lee
  6. Shunyu Li
  7. Byung-Suk Chung
  8. Min Seo
  9. Min-Ho Choi

Corresponding author

Correspondence toMin-Ho Choi.

Rights and permissions

About this article

Cite this article

Hong, ST., Lee, S.H., Lee, SJ. et al. Sustained-release praziquantel tablet: pharmacokinetics and the treatment of clonorchiasis in beagle dogs.Parasitol Res 91, 316–320 (2003). https://doi.org/10.1007/s00436-003-0958-7

Download citation

Keywords